Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-Charles Nault

Showing results (21-30 of 179) with videos related to

Pageof 18
Sort By:
Gastroenterology|March 15, 2013
Hepatocellular benign tumors-from molecular classification to personalized clinical careJean-Charles Nault, Paulette Bioulac-Sage, Jessica Zucman-Rossi
La Revue Du Praticien|March 15, 2019
Benign liver tumorsLorraine Blaise, Olivier Sutter, Marianne Ziol, et al.
Hepatic Oncology|March 8, 2021
Characterizing the mechanism behind the progression of NAFLD to hepatocellular carcinomaPierre Nahon, Manon Allaire, Jean-Charles Nault, et al.
United European Gastroenterology Journal|August 17, 2022
New concepts in the treatment of hepatocellular carcinomaSabrina Sidali, Eric Trépo, Olivier Sutter, et al.
The American Journal of Pathology|September 28, 2024
Morphomolecular Pathology and Genomic Insights into the Cells of Origin of Cholangiocarcinoma and Combined Hepatocellular-CholangiocarcinomaRachel V Guest, Benjamin Goeppert, Jean-Charles Nault, et al.
Nature Reviews. Gastroenterology & Hepatology|July 14, 2022
Benign liver tumours: understanding molecular physiology to adapt clinical managementJean-Charles Nault, Valérie Paradis, Maxime Ronot, et al.
Nature Reviews. Gastroenterology & Hepatology|June 30, 2019
The role of telomeres and telomerase in cirrhosis and liver cancerJean-Charles Nault, Massih Ningarhari, Sandra Rebouissou, et al.
Hepatic Oncology|October 11, 2018
Molecular classification of hepatocellular adenomas: impact on clinical practiceAnne-Laure Védie, Olivier Sutter, Marianne Ziol, et al.
Hepatology (Baltimore, Md.)|July 3, 2023
Indolent cancer and pattern of progression: Two missing parameters in trial design for hepatologyMassimo Iavarone, Jean-Charles Nault, Giuseppe Cabibbo, et al.
Gastroenterology|November 8, 2018
Genomic Medicine and Implications for Hepatocellular Carcinoma Prevention and TherapyRenumathy Dhanasekaran, Jean-Charles Nault, Lewis R Roberts, et al.
Pageof 18

Showing results (21-30 of 179) with videos related to

Sort By:
Pageof 18
Gastroenterology|March 15, 2013
Hepatocellular benign tumors-from molecular classification to personalized clinical careJean-Charles Nault, Paulette Bioulac-Sage, Jessica Zucman-Rossi
La Revue Du Praticien|March 15, 2019
Benign liver tumorsLorraine Blaise, Olivier Sutter, Marianne Ziol, et al.
Hepatic Oncology|March 8, 2021
Characterizing the mechanism behind the progression of NAFLD to hepatocellular carcinomaPierre Nahon, Manon Allaire, Jean-Charles Nault, et al.
United European Gastroenterology Journal|August 17, 2022
New concepts in the treatment of hepatocellular carcinomaSabrina Sidali, Eric Trépo, Olivier Sutter, et al.
The American Journal of Pathology|September 28, 2024
Morphomolecular Pathology and Genomic Insights into the Cells of Origin of Cholangiocarcinoma and Combined Hepatocellular-CholangiocarcinomaRachel V Guest, Benjamin Goeppert, Jean-Charles Nault, et al.
Nature Reviews. Gastroenterology & Hepatology|July 14, 2022
Benign liver tumours: understanding molecular physiology to adapt clinical managementJean-Charles Nault, Valérie Paradis, Maxime Ronot, et al.
Nature Reviews. Gastroenterology & Hepatology|June 30, 2019
The role of telomeres and telomerase in cirrhosis and liver cancerJean-Charles Nault, Massih Ningarhari, Sandra Rebouissou, et al.
Hepatic Oncology|October 11, 2018
Molecular classification of hepatocellular adenomas: impact on clinical practiceAnne-Laure Védie, Olivier Sutter, Marianne Ziol, et al.
Hepatology (Baltimore, Md.)|July 3, 2023
Indolent cancer and pattern of progression: Two missing parameters in trial design for hepatologyMassimo Iavarone, Jean-Charles Nault, Giuseppe Cabibbo, et al.
Gastroenterology|November 8, 2018
Genomic Medicine and Implications for Hepatocellular Carcinoma Prevention and TherapyRenumathy Dhanasekaran, Jean-Charles Nault, Lewis R Roberts, et al.
Pageof 18